» Articles » PMID: 1873451

Age at Menarche and Estrogen Concentrations of Adult Women

Overview
Specialties Oncology
Public Health
Date 1991 Jul 1
PMID 1873451
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

It has recently been reported that women with a recorded early menarche had approximately two-fold greater follicular phase serum E2 (estradiol) levels than women with menarche at age 13 or later. We have evaluated E1 (estrone) and E2 concentrations in the blood, and estrogen concentrations in the urine, in two groups of premenopausal women (mean ages 33 and 38 years) for categories of age at menarche. Study subjects were 106 Caucasian women in the United States (assessed for E1, E2, and urinary estrogens) and 39 women from Shanghai, China (assessed for E2). US subjects were classified according to whether their recalled menarche occurred before age 12, at age 12, or at age 13 or older. The mean age at recalled menarche of the Shanghai subjects was considerably older, and their ages at menarche were classified as less than age 15, age 15, and age 16 or older. We found little evidence in these premenopausal women in their thirties of an effect of age at menarche on estrogen levels. A large-scale study of women in the age range 20-40 years is necessary to investigate this important issue more thoroughly.

Citing Articles

Strong evidence supports the use of estradiol therapy for the treatment of vaginal inflammation: a two-way Mendelian randomization study.

Xu X, Liu Y, Feng W, Shen J Eur J Med Res. 2024; 29(1):339.

PMID: 38890725 PMC: 11186076. DOI: 10.1186/s40001-024-01914-4.


Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.

Jett S, Schelbaum E, Jang G, Yepez C, Dyke J, Pahlajani S Front Aging Neurosci. 2022; 14:948219.

PMID: 35928995 PMC: 9344010. DOI: 10.3389/fnagi.2022.948219.


Endogenous and Exogenous Estrogen Exposures: How Women's Reproductive Health Can Drive Brain Aging and Inform Alzheimer's Prevention.

Jett S, Malviya N, Schelbaum E, Jang G, Jahan E, Clancy K Front Aging Neurosci. 2022; 14:831807.

PMID: 35356299 PMC: 8959926. DOI: 10.3389/fnagi.2022.831807.


The Effects of Lifetime Estrogen Exposure on Breast Epigenetic Age.

Sehl M, Henry J, Storniolo A, Horvath S, Ganz P Cancer Epidemiol Biomarkers Prev. 2021; 30(6):1241-1249.

PMID: 33771849 PMC: 8172523. DOI: 10.1158/1055-9965.EPI-20-1297.


Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.

Modugno F, Fu Z, Jordan S, Group A, Chang-Claude J, Fortner R Eur J Epidemiol. 2020; 35(11):1025-1042.

PMID: 32959149 PMC: 7981786. DOI: 10.1007/s10654-020-00682-9.


References
1.
Key T, Chen J, Wang D, Pike M, Boreham J . Sex hormones in women in rural China and in Britain. Br J Cancer. 1990; 62(4):631-6. PMC: 1971493. DOI: 10.1038/bjc.1990.344. View

2.
Apter D, Reinila M, Vihko R . Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer. 1989; 44(5):783-7. DOI: 10.1002/ijc.2910440506. View

3.
MacMahon B, Trichopoulos D, Brown J, Andersen A, Cole P, Dewaard F . Age at menarche, urine estrogens and breast cancer risk. Int J Cancer. 1982; 30(4):427-31. DOI: 10.1002/ijc.2910300408. View

4.
Pike M, Krailo M, Henderson B, Casagrande J, Hoel D . 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983; 303(5920):767-70. DOI: 10.1038/303767a0. View

5.
Yu M, Gerkins V, Henderson B, Brown J, Pike M . Elevated levels of prolactin in nulliparous women. Br J Cancer. 1981; 43(6):826-31. PMC: 2010727. DOI: 10.1038/bjc.1981.121. View